Table 3 Antineoplastic drugs based on chemotherapy cycles.
Antineoplastic drugs | Total | PLT low (%) | P value | |
|---|---|---|---|---|
5750 | 590 (10.26) | |||
Alkylating agents | 0.01 | |||
Yes | 130 | 4 (3.08) | ||
No | 5620 | 586 (10.43) | ||
Anthracycline | 0.032 | |||
Yes | 121 | 20 (16.53) | ||
No | 5629 | 570 (10.13) | ||
Cisplatin | 0.942 | |||
Yes | 507 | 53 (10.45) | ||
No | 5243 | 537 (10.24) | ||
Carboplatin | 1 | |||
Yes | 614 | 63 (10.26) | ||
No | 5136 | 527 (10.26) | ||
Oxaliplatin | < 0.001 | |||
Yes | 1323 | 222 (16.78) | ||
No | 4427 | 368 (8.31) | ||
Fluorouracil | < 0.001 | |||
Yes | 1538 | 102 (6.63) | ||
No | 4212 | 488 (11.59) | ||
Capecitabine | < 0.001 | |||
yes | 524 | 95 (18.13) | ||
No | 5226 | 495 (9.47) | ||
S-1 | < 0.001 | |||
Yes | 283 | 57 (20.14) | ||
No | 5467 | 533 (9.75) | ||
Raltitrexed | 0.323 | |||
Yes | 498 | 58 (11.65) | ||
No | 5252 | 532 (10.13) | ||
Gemcitabine | 0.033 | |||
Yes | 500 | 37 (7.4) | ||
No | 5250 | 553 (10.53) | ||
Pemetrexed | 0.003 | |||
Yes | 272 | 13 (4.78) | ||
No | 5478 | 577 (10.53) | ||
Taxane | 0.002 | |||
Yes | 1036 | 79 (7.63) | ||
No | 4714 | 511 (10.84) | ||
Vinorelbine | 0.755 | |||
Yes | 112 | 10 (8.93) | ||
No | 5638 | 580 (10.29) | ||
Irinotecan | < 0.001 | |||
Yes | 1341 | 98 (7.31) | ||
No | 4409 | 492 (11.16) | ||
Etoposide | 0.412 | |||
Yes | 194 | 16 (8.25) | ||
No | 5556 | 574 (10.33) | ||
Hormones | 0.191 | |||
Yes | 90 | 5 (5.56) | ||
No | 5660 | 585 (10.34) | ||
ICIs | 0.299 | |||
Yes | 520 | 46 (8.85) | ||
No | 5230 | 544 (10.4) | ||
Monoclonal antibody | 0.034 | |||
Yes | 2511 | 233 (9.28) | ||
No | 3239 | 357 (11.02) | ||
TKIs | 0.001 | |||
Yes | 632 | 90 (14.24) | ||
No | 5118 | 500 (9.77) | ||
Fruquintinib | 0.002 | |||
Yes | 48 | 12 (25) | ||
No | 5702 | 578 (10.14) | ||
Everolimus | 0.582 | |||
Yes | 45 | 3 (6.67) | ||
No | 5705 | 587 (10.29) | ||
